Compound information
- Natural Products
- ZC79583
- Molecular Formula
- C12H13NO3
- Molecular Weight
- 219.089543276 g/mol
- Structure
-
- IUPAC Name
- (3R)-1-benzyl-4-oxo-pyrrolidine-3-carboxylic acid
- InChI
- InChI=1S/C12H13NO3/c14-11-8-13(7-10(11)12(15)16)6-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,15,16)/t10-/m1/s1
- InChI Key
- WAQWKBNCMREKAE-SNVBAGLBSA-N
- SMILES
- O=C(O)[C@@H]1CN(Cc2ccccc2)CC1=O
- Source
- ZINC000103622187
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 16 | Ring Count | 2 |
| Heteroatom Count | 4 | Rotatable Bond Count | 3 |
| Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 57.61 Å2 | LogP | 0.452 |
| LogS | -1.22 | LogD | -1.206 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.004 | Pgp substrate | 0.026 |
| HIA | 0.963 | F20 % | 0.993 |
| F30 % | 0.965 | Caco-2 | -5.219 |
| MDCK | -4.683 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.053 | PPB | 46.145 |
| VD | 1.743 | Fu | 0.252 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.486 |
| CYP2A6 substrate | 0.68 | CYP2B6 substrate | 0.742 |
| CYP2C19 inhibitor | 0.041 | CYP2C19 substrate | 0.689 |
| CYP2C8 substrate | 0.612 | CYP2C9 inhibitor | 0.006 |
| CYP2C9 substrate | 0.824 | CYP2D6 inhibitor | 0.012 |
| CYP2D6 substrate | 0.557 | CYP2E1 substrate | 0.142 |
| CYP3A4 inhibitor | 0.012 | CYP3A4 substrate | 0.288 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.955 | CL | 8.346 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.006 | Hepatotoxicity | 0.909 |
| Mutagenicity | 0.003 | Rat Oral Acute Toxicity | 0.218 |
| FDAMDD | 0.111 | Skin Sensitization | 0.991 |
| Carcinogenicity | 0.131 | Eye Corrosion | 0.036 |
| Eye Irritation | 0.961 | Respiratory Toxicity | 0.434 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | -0.383 | IGC50 | 2.169 |
| LC50FM | 2.908 | LC50DM | 3.903 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.551 | NR-AR-LBD | 0.488 |
| NR-AhR | 0.007 | NR-Aromatase | 0.025 |
| NR-ER | 0.411 | NR-ER-LBD | 0.254 |
| NR-PPAR-gamma | 0.342 | SR-ARE | 0.04 |
| SR-ATAD5 | 0.193 | SR-HSE | 0.046 |
| SR-MMP | 0.013 | SR-p53 | 0.044 |
Similar covalent drugs
No similar covalent drugs found for this compound.